OptimizeRx (OPRX) Current Assets (2010 - 2026)

OptimizeRx has disclosed Current Assets across 17 years of filings, most recently posting $54.1 million for Q2 2026.

• In Q2 2026, Current Assets changed 0.12% year-over-year to $54.1 million; the TTM figure through Jun 2026 stood at $54.1 million (changed 0.12% YoY), while the FY2025 annual figure was $64.7 million, up 19.91% from the prior year.
• Current Assets came in at $54.1 million for Q2 2026 at OptimizeRx, down from $56.2 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $112.7 million in Q1 2022 to a low of $46.0 million in Q2 2024.
• Average Current Assets over 5 years is $70.9 million, with a median of $56.2 million recorded in 2025.
• Year-over-year, Current Assets tumbled 49.57% in 2024 and gained 20.07% in 2025.
• Over 5 years, Current Assets stood at $98.6 million in 2022, then plunged by 44.88% to $54.3 million in 2023, then slipped by 0.66% to $54.0 million in 2024, then gained by 19.91% to $64.7 million in 2025, then dropped by 16.33% to $54.1 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $54.1 million in Q2 2026, $56.2 million in Q1 2026, and $64.7 million in Q4 2025.